project id: TCGA-CESC; case submitter id: TCGA-EK-A2PK; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.8; age at index: 43; days to birth: -15939; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 15939; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 12.0; figo stage: Stage IB1; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2043; initial weight: 110.0; oct embedded: false; preservation method: Unknown; sample id: 5f613800-55df-497f-a544-5b12cb9446ce; sample submitter id: TCGA-EK-A2PK-01A; portion id: c519ac88-b5d6-468d-8914-4745902a50f8; portion submitter id: TCGA-EK-A2PK-01A-11; slide id: ca1c2135-1c36-4a95-83b7-686649ed3512; slide submitter id: TCGA-EK-A2PK-01A-01-TS1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 6.0; percent tumor cells: 93.0; percent tumor nuclei: 90.0; section location: TOP;